Sector
Recent investment activity
KANDO id: 274503
Corporate information
Official name
Eli Lilly & Co
Funding rounds
Investment preferences
Top investment portfolio themes
blood cancer (1)
cancer treatment (1)
Actual initial investment stage
Investment activity status
Active investor
Selected investments
Displaying 1 - 6 of 6Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Ajax Therapeutics Inc | Blood cancer biotech. | Series C Initial investment | ||||
Imclone Systems | Acquisition Initial investment led the round USD 7,133,620,000 (USD 7,133,620,000) | |||||
INext Fund | Fund Closing | |||||
Mission Bay Capital III | Fund Closing | |||||
Novartis Animal Health | Acquisition Initial investment led the round USD 5,400,000,000 (USD 5,400,000,000) | |||||
Zephyr AI Inc | Precision medicine startup. | Series A Initial investment |